Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
The unique ORS effervescent tablet has been developed according to the latest guidelines of the WHO. It has a substantial marketshare in several countries. We are looking for partners to further expand this success. More
Superior Alternative to Pads and Tampons More
Supercritical fluid crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More
Oestradiol Spray for Women: Oestradiol MDTS for the Treatment of Menopausal Symptoms More
Development of a Novel Treatment of Bedsores and Other Dermal Ulcers: A Spray Formulation Containing Recombinant Human Basic Fibroblast Growth Factor More
MediCinus to Ease the Administration of Liquid Medicines to Children: Distribution Partners Sought for USA/Europe/Asia More
Related Reports
Market Research Reports provided by reports.iptechex.com
Jun 2009 - 110 pages - $1,040
Nov 2011 - 7 pages - $3,835
Jun 2009 - 472 pages - $3,140
Nov 2010 - 428 pages - $2,695
Nov 2010 - 185 pages - $1,495
Jan 2011 - 124 pages - $1,740
Jun 2009 - 118 pages - $1,040
Nov 2009 - 830 pages - $1,040
Jun 2008 - 175 pages - $3,835
Your selection
Browse By
- Industry sector
- Intravesical
- Nasal
- Nasal topical
- Ophthalmic
- Oral liquid
- Oral solid
- Otic
- Parenteral
- Pulmonary
- Rectal
- Systemic
- Topical
- Vaginal
- Therapeutic target
- Amenorrahea
- Androgen deficiency
- Endocrine system
- Estrogen replacement
- Growth disorders
- Hormonal disorder (other)
- Hormone replacement therapy
- Hurler's syndrome
- Hypogonadism
- Hypothalamic
- Menopause
- Pancreatic exocrine insufficiency
- Sex hormone (other)
- Testosterone replacement
- Thyroid disorders
- Turner's syndrome
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us